HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eiji Suzuki Selected Research

Immunotherapy

5/2019Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.
11/2010Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms.
6/2007Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects.
9/2005Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eiji Suzuki Research Topics

Disease

32Neoplasms (Cancer)
04/2022 - 01/2002
21Breast Neoplasms (Breast Cancer)
08/2021 - 03/2006
12Rheumatoid Arthritis
08/2021 - 06/2004
5Autoimmune Diseases (Autoimmune Disease)
06/2022 - 04/2004
5Adult-Onset Still's Disease
01/2021 - 12/2017
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2020 - 04/2004
5Inflammation (Inflammations)
01/2020 - 09/2014
4Arthritis (Polyarthritis)
01/2020 - 10/2004
3Dermatomyositis (Dermatopolymyositis)
04/2022 - 01/2017
3Takayasu Arteritis (Arteritis, Takayasu's)
04/2022 - 06/2013
3Triple Negative Breast Neoplasms
12/2021 - 07/2020
3Mixed Connective Tissue Disease (MCTD)
01/2020 - 01/2013
3Hypertension (High Blood Pressure)
08/2019 - 08/2009
3Renal Insufficiency (Renal Failure)
01/2016 - 06/2008
3Neoplasm Metastasis (Metastasis)
08/2015 - 01/2004
3Mental Disorders (Mental Disorder)
01/2014 - 11/2002
3Malignant Mesothelioma
11/2010 - 09/2004
2Myositis (Idiopathic Inflammatory Myopathies)
04/2022 - 05/2019
2Serositis
01/2022 - 03/2015
2Thrombotic Thrombocytopenic Purpura
01/2020 - 01/2013
2Shock
12/2019 - 01/2006
2Rheumatic Diseases (Rheumatism)
11/2019 - 12/2017
2Genetic Predisposition to Disease (Genetic Predisposition)
09/2019 - 12/2017
2Liver Diseases (Liver Disease)
08/2019 - 01/2003
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2019 - 12/2018
2Bone Resorption
08/2018 - 01/2014
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2017 - 06/2013
2Diabetes Mellitus
01/2017 - 01/2016
2Lung Neoplasms (Lung Cancer)
11/2010 - 12/2005
2Coronary Artery Disease (Coronary Atherosclerosis)
10/2008 - 12/2005
2Mesothelioma
03/2007 - 12/2005
2Osteoarthritis
08/2006 - 06/2004
2Colorectal Neoplasms (Colorectal Cancer)
01/2006 - 01/2004

Drug/Important Bio-Agent (IBA)

9Pharmaceutical PreparationsIBA
08/2021 - 09/2005
7AntibodiesIBA
04/2022 - 10/2004
7CytokinesIBA
01/2021 - 10/2008
7Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2015
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2018 - 06/2004
5SteroidsIBA
06/2022 - 12/2017
5Trastuzumab (Herceptin)FDA Link
03/2021 - 03/2007
5human ERBB2 proteinIBA
02/2020 - 03/2007
5Proteins (Proteins, Gene)FDA Link
12/2019 - 01/2004
4EnzymesIBA
04/2022 - 10/2004
4Immunoglobulin G (IgG)IBA
01/2021 - 09/2004
4AntigensIBA
01/2020 - 08/2006
4thiamine triphosphorate (TTP)IBA
01/2020 - 06/2004
4ChemokinesIBA
08/2019 - 12/2012
4TristetraprolinIBA
01/2008 - 06/2004
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2006 - 11/2002
3Immunoglobulins (Immunoglobulin)IBA
06/2022 - 11/2020
3AutoantibodiesIBA
04/2022 - 06/2013
3tocilizumab (atlizumab)FDA Link
04/2022 - 11/2016
3ColchicineFDA LinkGeneric
01/2022 - 05/2018
3Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2018
3Serotonin (5 Hydroxytryptamine)IBA
01/2021 - 09/2015
3Estrogen ReceptorsIBA
02/2020 - 11/2014
3Hormones (Hormone)IBA
02/2020 - 03/2011
3ImmunosorbentsIBA
05/2019 - 01/2006
3TabletsIBA
01/2018 - 01/2016
3Psychotropic Drugs (Psychoactive Drugs)IBA
01/2018 - 11/2002
3Biological ProductsIBA
01/2016 - 01/2004
3Fluorouracil (Carac)FDA LinkGeneric
11/2011 - 01/2002
3GemcitabineFDA Link
11/2010 - 09/2005
3Complementary DNA (cDNA)IBA
08/2006 - 01/2004
2Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2022 - 01/2020
2GlucocorticoidsIBA
04/2022 - 10/2021
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
03/2022 - 06/2013
2Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 01/2009
2ErbB Receptors (EGF Receptor)IBA
03/2021 - 04/2018
2Granzymes (Granzyme)IBA
03/2021 - 08/2015
2Anti-Citrullinated Protein AntibodiesIBA
01/2021 - 01/2020
2Dopamine (Intropin)FDA LinkGeneric
01/2021 - 09/2015
2InflammasomesIBA
01/2021 - 12/2018
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 11/2011
2Monoclonal AntibodiesIBA
12/2019 - 08/2009
2HLA-DRB1 Chains (HLA DRB1)IBA
09/2019 - 12/2017
2Carrier Proteins (Binding Protein)IBA
08/2019 - 12/2018
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2019 - 01/2018
2Infliximab (Remicade)FDA Link
08/2018 - 07/2007
2Letrozole (Femara)FDA LinkGeneric
04/2018 - 11/2014
2Zoledronic Acid (Zometa)FDA Link
04/2018 - 11/2014
2Valproic Acid (Depakote)FDA LinkGeneric
01/2018 - 09/2015
2Epidermal Growth Factor (EGF)IBA
09/2017 - 01/2004
2Messenger RNA (mRNA)IBA
01/2017 - 06/2004
2Prednisolone (Predate)FDA LinkGeneric
01/2017 - 01/2009
2Hydroxyindoleacetic AcidIBA
01/2016 - 03/2012
2OsteopontinIBA
01/2014 - 08/2009
2Transforming Growth Factors (Transforming Growth Factor)IBA
07/2013 - 09/2004
2AutoantigensIBA
06/2013 - 10/2004
2Cisplatin (Platino)FDA LinkGeneric
11/2010 - 01/2002
2CalciumIBA
10/2008 - 12/2005
2T-Cell Intracellular Antigen-1IBA
07/2007 - 08/2006
2Transforming Growth Factor beta (TGF-beta)IBA
03/2007 - 09/2004

Therapy/Procedure

17Therapeutics
04/2022 - 09/2004
7Drug Therapy (Chemotherapy)
12/2021 - 09/2005
4Neoadjuvant Therapy
07/2021 - 03/2006
4Radiotherapy
12/2019 - 01/2017
4Immunotherapy
05/2019 - 09/2005
3Segmental Mastectomy (Lumpectomy)
07/2019 - 03/2006
2Lasers (Laser)
01/2020 - 01/2016